These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15779241)

  • 1. The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease.
    Golde TE
    Brain Pathol; 2005 Jan; 15(1):84-7. PubMed ID: 15779241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease.
    Golde TE; Dickson D; Hutton M
    Curr Alzheimer Res; 2006 Dec; 3(5):421-30. PubMed ID: 17168641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.
    Levin J; Vöglein J; Quiroz YT; Bateman RJ; Ghisays V; Lopera F; McDade E; Reiman E; Tariot PN; Morris JC
    Alzheimers Dement; 2022 Dec; 18(12):2687-2698. PubMed ID: 35212149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
    Chételat G
    Nat Rev Neurol; 2013 Mar; 9(3):123-4. PubMed ID: 23399647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovascular pathways and Alzheimer amyloid beta-peptide.
    Zlokovic BV; Deane R; Sallstrom J; Chow N; Miano JM
    Brain Pathol; 2005 Jan; 15(1):78-83. PubMed ID: 15779240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?
    Panza F; Lozupone M; Seripa D; Imbimbo BP
    Ann Neurol; 2019 Mar; 85(3):303-315. PubMed ID: 30635926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advancements in Aβ luminescent probes and inhibitors of Aβ aggregation.
    Ma DL; Chan DS; Ma VP; Leung KH; Zhong HJ; Leung CH
    Curr Alzheimer Res; 2012 Sep; 9(7):830-43. PubMed ID: 22631884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
    McGeer PL; McGeer EG
    Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
    Watt AD; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease.
    Hoozemans JJ; Chafekar SM; Baas F; Eikelenboom P; Scheper W
    Curr Med Chem; 2006; 13(22):2599-605. PubMed ID: 17017913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.